Translating pharmacogenomics: challenges on the road to the clinic
about
Pharmacometabolomics-aided Pharmacogenomics in Autoimmune DiseaseBiobanks: importance, implications and opportunities for genetic counselorsYeast toxicogenomics: genome-wide responses to chemical stresses with impact in environmental health, pharmacology, and biotechnologyUsing expression and genotype to predict drug response in yeastNifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolyticPharmacogenomics, evidence, and the role of payers.A health services research agenda for cellular, molecular and genomic technologies in cancer care.Structuring public engagement for effective input in policy development on human tissue biobankingThe International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment.Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors.Improving the prediction of pharmacogenes using text-derived drug-gene relationships.Influence of pharmacogenetic variability on the pharmacokinetics and toxicity of the aurora kinase inhibitor danusertib.Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.Concept-based learning of personalized prescribing.Personalised medicine: not just in our genes.Pharmacogenetics studies in STAR*D: strengths, limitations, and resultsPharmacogenomics with antidepressants in the STAR*D study.Use of plasmid-derived external quality control samples in pharmacogenetic testing.Estrogen exposure, metabolism, and enzyme variants in a model for breast cancer risk prediction.From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogenetics.Theranostics in primary care: pharmacogenomics tests and beyond.Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexate.Pharmacometabonomics and personalized medicine.Stakeholder views on pharmacogenomic testing.Pharmacogenetics of taste: turning bitter pills sweet?Pharmacogenetics of drug response in Parkinson's disease.Genome-wide association studies in pharmacogenomics of antidepressants.Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx).Personalized medicine: Genetic risk prediction of drug response.Pharmacogenetic Testing: Application in Mental Health Prescribing.Economic Evaluations of Pharmacogenetic Approaches in Infectious Diseases: A Review of Current Approaches and Evaluation of Critical Aspects Affecting their Quality.Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.Concordance of genotype for polymorphisms in DNA isolated from peripheral blood and colorectal cancer tumor samples.Génome Québec & Montreal Heart Institute Pharmacogenomics Centre: a translational pharmacogenomics platform--from R&D to the clinic.A nationwide survey of pharmacists' perception of pharmacogenetics in the context of a clinical decision support system containing pharmacogenetics dosing recommendations.A knowledge-driven conditional approach to extract pharmacogenomics specific drug-gene relationships from free text.Using Bayesian-PBPK modeling for assessment of inter-individual variability and subgroup stratification.Pharmacogenomics in Primary Care: A Crucial Entry Point for Global Personalized Medicine?Gene expression biomarkers of response to citalopram treatment in major depressive disorderQuantitative- and phospho-proteomic analysis of the yeast response to the tyrosine kinase inhibitor imatinib to pharmacoproteomics-guided drug line extension.
P2860
Q26748481-DBACD442-B88C-44EF-A23A-C1B46DB4A04EQ27010377-86576BB7-E96C-4245-A60C-1802F2CAAF26Q28383634-BBAEF3DB-4102-4E9C-A2F4-EF516624DCDCQ28476059-3A76D343-8E7D-4EBD-8E2E-6910E170D45CQ33688800-C6463261-C79C-4F0B-9D6B-C21D47C0AA0EQ33721099-94F13E92-8CA4-491C-8B9B-CE15376F0CAFQ33749983-F2F4A267-C8EF-46E8-8A74-00EBA9C4B4B6Q33869885-510A7347-5563-4DE7-951C-8D2288A50647Q33929926-957F71D3-D676-4F36-AE79-45DF5BFB3344Q34467460-ECBF11DF-85F5-4AAD-B36A-3B822040566DQ34974251-E3F31EEF-C8D8-40B8-B353-B9260A267276Q35178065-9EAE860E-2D5A-47CA-B0CD-CBCEE5134184Q35812195-86B0DE13-3F96-4F18-8F0B-821FE38A1D6FQ36335956-4BE8961A-E057-49E8-BFB1-5C64128724AEQ36396620-078BC504-564D-4E92-9FFD-52DCE3E79EA1Q37178537-E506C54B-15A9-47DC-865B-84440C6F7787Q37205961-F3288AB7-F245-43AE-8A82-25B323690853Q37264536-7CE0BE21-99CE-48B0-A7FE-BBB41C229592Q37313821-28F47DFC-9437-40B6-9993-B097FEE90C86Q37806982-A0AD0214-8661-4FD5-B27E-4DC0F8341E15Q38068223-B52EB70F-094D-4A8C-A858-BF9EE1601CD7Q38068540-64A4337B-A1EB-4193-A348-7D6DF1E5BFAAQ38124254-C711598B-085F-4993-80E3-DE4CB746AE92Q38156135-25B36F31-6079-42AE-8DE1-117CC7FADE1CQ38170459-5BD8C71F-065E-431C-B350-A580FE48F903Q38250117-5659BD00-3BA3-40E2-9020-72F5B2F5A25BQ38444447-5801EDF0-503B-4782-BF7E-DA3106281D91Q38663993-4B30F3FD-AF0A-42B6-9EF2-DFD9BCCC5E22Q38756015-E264A0FF-735B-4DE3-9D2D-DFF7B17A18E2Q38786972-3993C393-7D78-4C4D-B922-F73EB5456234Q38904691-C3B1A564-D3B5-4826-A75D-5C35B1868D9FQ39062032-AA344EA1-3D68-40E7-A237-7992E2213452Q39307013-4E2DFE6D-4EE5-452B-9492-DBC0AC7DA073Q40036505-DBD8DF60-E953-4EAB-A324-1AC7D59B8179Q40368410-66844FF6-6DA1-4A94-8B5E-B1D5C65B9988Q41574202-E95B4F86-80EA-4A9F-A495-CC3EB0AD4677Q41692388-9F91EF18-EB79-4884-A09F-9294609E3CEEQ41766266-E6DB4084-494B-4D4C-B9D4-104881A7A1A6Q41910462-8DCD1691-B21D-42CE-8B59-D92E518BE86AQ42586969-22D69897-5C71-4DD5-9F18-485CACECF5B6
P2860
Translating pharmacogenomics: challenges on the road to the clinic
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Translating pharmacogenomics: challenges on the road to the clinic
@ast
Translating pharmacogenomics: challenges on the road to the clinic
@en
Translating pharmacogenomics: challenges on the road to the clinic
@en-gb
Translating pharmacogenomics: challenges on the road to the clinic
@nl
type
label
Translating pharmacogenomics: challenges on the road to the clinic
@ast
Translating pharmacogenomics: challenges on the road to the clinic
@en
Translating pharmacogenomics: challenges on the road to the clinic
@en-gb
Translating pharmacogenomics: challenges on the road to the clinic
@nl
altLabel
Translating Pharmacogenomics: Challenges on the Road to the Clinic
@en
prefLabel
Translating pharmacogenomics: challenges on the road to the clinic
@ast
Translating pharmacogenomics: challenges on the road to the clinic
@en
Translating pharmacogenomics: challenges on the road to the clinic
@en-gb
Translating pharmacogenomics: challenges on the road to the clinic
@nl
P2093
P2860
P921
P1433
P1476
Translating pharmacogenomics: challenges on the road to the clinic
@en
P2093
Elisabeth G E de Vries
Hans Gelderblom
Jesse J Swen
Julia Kirchheiner
Tom W Huizinga
Willem J J Assendelft
P2860
P356
10.1371/JOURNAL.PMED.0040209
P407
P577
2007-08-01T00:00:00Z